These in vitro results provide a preclinical rationale for in vivo testing of TAM , interleukin-2 ( IL-2 ) , and breast cancer reactive antibody-dependent cellular cytotoxicity facilitating antibody in patients with refractory or high risk breast cancer .
these in vitro results provide a preclinical rationale for in vivo testing of tam , interleukin-2 ( il-2 ) , and breast cancer reactive antibody-dependent cellular cytotoxicity facilitating antibody in patients with refractory or high risk breast cancer .
O O O O O O O O O O O O O B-other_organic_compound O B-protein_molecule O B-protein_molecule O O O B-other_name I-other_name I-other_name I-other_name I-other_name I-other_name O O O B-multi_cell O O O B-other_name I-other_name I-other_name I-other_name O